Evidence map›Paper›PMID 32697796›Full record

Observational studyPloS one2020

The applicability of commonly used predictive scoring systems in Indigenous Australians with sepsis: An observational study.

Josh Hanson, Simon Smith, James Brooks, Taissa Groch, Sayonne Sivalingam, Venessa Curnow, Angus Carter, Satyen Hargovan

Open access · goldAbstract readComparative StudyObservational Study
In one paragraph

Observational study in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. The aetiology and incidence of infective endocarditis in people living with rheumatic heart disease in tropical Australia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Josh HansonDepartment of Medicine, Cairns Hospital, Cairns, Queensland, Australia.ORCID 0000-0002-1423-3839
Simon SmithDepartment of Medicine, Cairns Hospital, Cairns, Queensland, Australia.
James BrooksDepartment of Intensive Care Medicine, Cairns Hospital, Cairns, Queensland, Australia.
Taissa GrochDepartment of Anaesthetics, Cairns Hospital, Cairns, Queensland, Australia.
Sayonne SivalingamDepartment of Intensive Care Medicine, Cairns Hospital, Cairns, Queensland, Australia.
Venessa CurnowAboriginal and Torres Strait Islander Health, Torres and Cape Hospital and Health Service, Cooktown, Queensland, Australia.
Angus CarterDepartment of Intensive Care Medicine, Cairns Hospital, Cairns, Queensland, Australia.
Satyen HargovanDepartment of Intensive Care Medicine, Cairns Hospital, Cairns, Queensland, Australia.
Cairns Hospital · AUAustralian Institute of Aboriginal and Torres Strait Islander Studies · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIndigenous Australians suffer a disproportionate burden of sepsis, however, the performance of scoring systems that predict mortality in Indigenous patients with critical illness is incompletely defined. MATERIALS AND

methodsThe study was performed at an Australian tertiary-referral hospital between January 2014 and June 2017, and enrolled consecutive Indigenous and non-Indigenous adults admitted to ICU with sepsis. The ability of the ANZROD, APACHE-II, APACHE-III, SAPS-II, SOFA and qSOFA scores to predict death before ICU discharge in the two populations was compared.

resultsThere were 442 individuals enrolled in the study, 145 (33%) identified as Indigenous. Indigenous patients were younger than non-Indigenous patients (median (interquartile range (IQR) 53 (43-60) versus 65 (52-73) years, p = 0.0001) and comorbidity was more common (118/145 (81%) versus 204/297 (69%), p = 0.005). Comorbidities that were more common in the Indigenous patients included diabetes mellitus (84/145 (58%) versus 67/297 (23%), p<0.0001), renal disease (56/145 (39%) versus 29/297 (10%), p<0.0001) and cardiovascular disease (58/145 (40%) versus 83/297 (28%), p = 0.01). The use of supportive care (including vasopressors, mechanical ventilation and renal replacement therapy) was similar in Indigenous and non-Indigenous patients, and the two populations had an overall case-fatality rate that was comparable (17/145 (12%) and 38/297 (13%) (p = 0.75)), although Indigenous patients died at a younger age (median (IQR): 54 (50-60) versus 70 (61-76) years, p = 0.0001). There was no significant difference in the ability of any the scores to predict mortality in the two populations.

conclusionsAlthough the crude case-fatality rates of Indigenous and non-Indigenous Australians admitted to ICU with sepsis is comparable, Indigenous patients die at a much younger age. Despite this, the ability of commonly used scoring systems to predict outcome in Indigenous Australians is similar to that of non-Indigenous Australians, supporting their use in ICUs with a significant Indigenous patient population and in clinical trials that enrol Indigenous Australians.

Indexed as

Australian Aboriginal and Torres Strait Islander PeoplesRisk AssessmentSepsisAgedAge FactorsAustraliaFemaleHospital MortalityHumansIntensive Care UnitsMaleMiddle AgedRenal Replacement TherapyRespiration, ArtificialRetrospective StudiesSeverity of Illness IndexVasoconstrictor Agents

Identifiers

PMID32697796
PMCPMC7375531
OpenAlexW3045067882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.